FDA Seeks Public Comment on Proposed Rule for Drug Registration and Listing

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed rule requiring the registration of drug producers and the listing of drugs in commercial distribution. The agency must publish this notice in the Federal Register and allow 60 days for public feedback under the Paperwork Reduction Act of 1995.